Marine Natural Products and Coronary Artery Disease

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2021 Oct 8

PMID 34621803

Citations 10

Authors

Bo Liang

Xin-Yi Cai

Ning Gu

Affiliations

Soon will be listed here.

Abstract

Coronary artery disease is the major cause of mortality worldwide, especially in low- and middle-income earners. To not only reduce angina symptoms and exercise-induced ischemia but also prevent cardiovascular events, pharmacological intervention strategies, including antiplatelet drugs, anticoagulant drugs, statins, and other lipid-lowering drugs, and renin-angiotensin-aldosterone system blockers, are conducted. However, the existing drugs for coronary artery disease are incomprehensive and have some adverse reactions. Thus, it is necessary to look for new drug research and development. Marine natural products have been considered a valuable source for drug discovery because of their chemical diversity and biological activities. The experiments and investigations indicated that several marine natural products, such as organic small molecules, polysaccharides, proteins, and bioactive peptides, and lipids were effective for treating coronary artery disease. Here, we particularly discussed the functions and mechanisms of active substances in coronary artery disease, including antiplatelet, anticoagulant, lipid-lowering, anti-inflammatory, and antioxidant activities.

Citing Articles

Association of serum cystatin C level and major adverse cardiovascular events in patients with percutaneous coronary intervention.

Xiao Z, Riletu A, Yan X, Meng Q, Zhang W, Zhang N Cardiovasc Diagn Ther. 2024; 14(4):621-629.

PMID: 39263480 PMC: 11384458. DOI: 10.21037/cdt-23-482.

Advancing Research on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Scientometric Analysis.

Matin A, Chaudhry G, Azra M, Gazali M, Yeong Y, Tengku Muhammad T Malays J Med Sci. 2024; 31(4):14-34.

PMID: 39247108 PMC: 11377008. DOI: 10.21315/mjms2024.31.4.2.

Natural product-based treatment potential for type 2 diabetes mellitus and cardiovascular disease.

Shrivastav D, Kumbhakar S, Srivastava S, Singh D World J Diabetes. 2024; 15(7):1603-1614.

PMID: 39099809 PMC: 11292323. DOI: 10.4239/wjd.v15.i7.1603.

Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes.

Giuliani M, Bigossi G, Lai G, Marcozzi S, Brunetti D, Malavolta M Mar Drugs. 2024; 22(5).

PMID: 38786601 PMC: 11123485. DOI: 10.3390/md22050210.

Study on the mechanism of action of colchicine in the treatment of coronary artery disease based on network pharmacology and molecular docking technology.

Yu Y, Zhou M, Long X, Yin S, Hu G, Yang X Front Pharmacol. 2023; 14:1147360.

PMID: 37405052 PMC: 10315633. DOI: 10.3389/fphar.2023.1147360.

References

Kastana P, Choleva E, Poimenidi E, Karamanos N, Sugahara K, Papadimitriou E . Insight into the role of chondroitin sulfate E in angiogenesis. FEBS J. 2019; 286(15):2921-2936. DOI: 10.1111/febs.14830. View

Zula A, Bedziak I, Kikelj D, Ilas J . Synthesis and Evaluation of Spumigin Analogues Library with Thrombin Inhibitory Activity. Mar Drugs. 2018; 16(11). PMC: 6266488. DOI: 10.3390/md16110413. View

Yan L, Wang D, Yu Y, Zhang F, Ye X, Linhardt R . Fucosylated Chondroitin Sulfate 9-18 Oligomers Exhibit Molecular Size-Independent Antithrombotic Activity while Circulating in the Blood. ACS Chem Biol. 2020; 15(8):2232-2246. DOI: 10.1021/acschembio.0c00439. View

Liu X, Hao J, Shan X, Zhang X, Zhao X, Li Q . Antithrombotic activities of fucosylated chondroitin sulfates and their depolymerized fragments from two sea cucumbers. Carbohydr Polym. 2016; 152:343-350. DOI: 10.1016/j.carbpol.2016.06.106. View

Qiu Y, Jiang H, Fu L, Ci F, Mao X . Porphyran and oligo-porphyran originating from red algae Porphyra: Preparation, biological activities, and potential applications. Food Chem. 2021; 349:129209. DOI: 10.1016/j.foodchem.2021.129209. View

Rousseau G . Microbiota, a New Playground for the Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Diseases. Mar Drugs. 2021; 19(2). PMC: 7931107. DOI: 10.3390/md19020054. View

Lee K, Kwon Y, Kim S, Moon D, Kim H, Nam K . Regulatory mechanism of mineral-balanced deep sea water on hypocholesterolemic effects in HepG2 hepatic cells. Biomed Pharmacother. 2016; 86:405-413. DOI: 10.1016/j.biopha.2016.12.046. View

Bai M, Wang X . Risk factors associated with coronary heart disease in women: a systematic review. Herz. 2019; 45(Suppl 1):52-57. DOI: 10.1007/s00059-019-4835-2. View

Zhao L, Li J, Yuan F, Li M, Zhang Q, Huang Y . Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice. Mar Drugs. 2015; 13(4):2306-26. PMC: 4413213. DOI: 10.3390/md13042306. View

10.

Wu S, Mayneris-Perxachs J, Lovegrove J, Todd S, Yaqoob P . Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype. Am J Clin Nutr. 2014; 100(5):1232-43. DOI: 10.3945/ajcn.114.088880. View

11.

Deng Z, Liu Y, Wang J, Wu S, Geng L, Sui Z . Antihypertensive Effects of Two Novel Angiotensin I-Converting Enzyme (ACE) Inhibitory Peptides from (Rhodophyta) in Spontaneously Hypertensive Rats (SHRs). Mar Drugs. 2018; 16(9). PMC: 6163600. DOI: 10.3390/md16090299. View

12.

Qiu X, Zhong W . Antihyperglycemic and Antihyperlipidemic Effects of Low-molecular-weight Carrageenan in Rats. Open Life Sci. 2021; 13:379-384. PMC: 7874689. DOI: 10.1515/biol-2018-0046. View

13.

Zhao J, Cao Q, Xing M, Xiao H, Cheng Z, Song S . Advances in the Study of Marine Products with Lipid-Lowering Properties. Mar Drugs. 2020; 18(8). PMC: 7459887. DOI: 10.3390/md18080390. View

14.

Liang B, Zhang X, Gu N . Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease. BMC Complement Med Ther. 2020; 20(1):345. PMC: 7664106. DOI: 10.1186/s12906-020-03133-w. View

15.

Lin G, Wu D, Xiao X, Huang Q, Chen H, Liu D . Structural characterization and antioxidant effect of green alga Enteromorpha prolifera polysaccharide in Caenorhabditis elegans via modulation of microRNAs. Int J Biol Macromol. 2019; 150:1084-1092. DOI: 10.1016/j.ijbiomac.2019.10.114. View

16.

Thorlacius H, Vollmar B, Seyfert U, Vestweber D, Menger M . The polysaccharide fucoidan inhibits microvascular thrombus formation independently from P- and L-selectin function in vivo. Eur J Clin Invest. 2000; 30(9):804-10. DOI: 10.1046/j.1365-2362.2000.00704.x. View

17.

Wang H, Hung T, Wei J, Chiang A . Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovasc Res. 2004; 61(1):169-76. DOI: 10.1016/j.cardiores.2003.11.002. View

18.

Wahab H, Pham N, Muhammad T, Hooper J, Quinn R . Merosesquiterpene Congeners from the Australian Sponge Hyrtios digitatus as Potential Drug Leads for Atherosclerosis Disease. Mar Drugs. 2016; 15(1). PMC: 5295226. DOI: 10.3390/md15010006. View

19.

Calder P . The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res. 2012; 56(7):1073-80. DOI: 10.1002/mnfr.201100710. View

20.

Zhang Y, Ahmad K, Ullah Khan F, Yan S, Ihsan A, Ding Q . Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway. Chem Biol Interact. 2019; 305:54-65. DOI: 10.1016/j.cbi.2019.03.027. View